- Home
- CDXS vs WSBF Comparison
CDXS vs WSBF Comparison
Compare CDXS & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- WSBF
- Stock Information
- Founded
- CDXS 2002
- WSBF 1921
- Country
- CDXS United States
- WSBF United States
- Employees
- CDXS N/A
- WSBF N/A
- Industry
- CDXS Major Chemicals
- WSBF Savings Institutions
- Sector
- CDXS Industrials
- WSBF Finance
- Exchange
- CDXS Nasdaq
- WSBF Nasdaq
- Market Cap
- CDXS 201.3M
- WSBF 240.7M
- IPO Year
- CDXS 2010
- WSBF N/A
- Fundamental
- Price
- CDXS $2.30
- WSBF $12.92
- Analyst Decision
- CDXS Buy
- WSBF
- Analyst Count
- CDXS 2
- WSBF 0
- Target Price
- CDXS $11.00
- WSBF N/A
- AVG Volume (30 Days)
- CDXS 1.0M
- WSBF 49.7K
- Earning Date
- CDXS 05-14-2025
- WSBF 07-24-2025
- Dividend Yield
- CDXS N/A
- WSBF 4.63%
- EPS Growth
- CDXS N/A
- WSBF 95.86
- EPS
- CDXS N/A
- WSBF 1.02
- Revenue
- CDXS $49,815,000.00
- WSBF $133,551,000.00
- Revenue This Year
- CDXS $2.41
- WSBF N/A
- Revenue Next Year
- CDXS $34.28
- WSBF N/A
- P/E Ratio
- CDXS N/A
- WSBF $12.70
- Revenue Growth
- CDXS N/A
- WSBF 1.81
- 52 Week Low
- CDXS $1.90
- WSBF $11.61
- 52 Week High
- CDXS $6.08
- WSBF $16.86
- Technical
- Relative Strength Index (RSI)
- CDXS 44.61
- WSBF 56.87
- Support Level
- CDXS $2.30
- WSBF $12.49
- Resistance Level
- CDXS $2.56
- WSBF $12.90
- Average True Range (ATR)
- CDXS 0.20
- WSBF 0.26
- MACD
- CDXS -0.01
- WSBF 0.04
- Stochastic Oscillator
- CDXS 46.67
- WSBF 63.53
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.